Job title: Principal Scientist & Group Leader
Dr. Ling Xu obtained her Ph.D. from University of Colorado at Boulder, where she was trained as an enzymologist. She has over 18 years’ experience with mass spectrometry application in the areas of characterization and quantification of both small and large molecules. She worked as a Senior Research Associate at a proteomic mass spectrometry central lab at University of Toronto for five years. She has been working at Millennium Pharmaceutical/Takeda Boston for over nine years leading bioanalysis of antibody drug conjugates. Before that, she did research at Brigham Woman Hospital /Harvard School of Medicine for around a year as a Research Associate on structural elucidation of bioactive small molecules that activate the resolution of acute inflammation. Dr. Ling Xu joined Mersana Therapeutics, Inc. in 2017.
Antibody-Drug Conjugate Bioanalytical Strategies & Applications in Nonclinical & Clinical Studies 2:00 pm
Total antibody and antibody conjugated drug 2-in-1 assay development and validation Review a nonclinical case study PK/PD simultaneous measurement in mouse model using microsampling to support nonclinical studiesRead more
day: Day Two